A transcriptome-wide association study integrating multi-omics bioinformatics and Mendelian randomization reveals the prognostic value of ADAMDEC1 in colon cancer
Archives of Toxicology · 2025-02 · 99 (2) · 645-665
DOI: 10.1007/s00204-024-03910-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 16.12.2024. Verfasst von Cong Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Transcriptome. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Youth Science Foundation Project, Science and Technology Research Program of Chongqing Municipal Education Commission, Chongqing Maternal and Child Disease Prevention and Control and Public Health Research Center Open Project.
Abstract (Originalsprache)
An abundant amount of colon cancers is diagnosed every year, accounting for 9% of malignant tumors. Even with the progress of relevant research, the 5-year survival rate for colon cancer is still less than 60%, indicating that improving the prognosis of colon cancer is still a challenge that needs to be overcome. This study employed the algorithm "scissor" to integrate the single-cell sequencing data and bulk transcriptome data with prognosis information to predict prognosis-associated cells (PAC). Summary-data-based Mendelian randomization (SMR) analysis was conducted using expression quantitative trait loci data and GWAS data to identify genes having causal associations with prognosis phenotype in colon cancer patients and five traditional two-sample Mendelian randomization methods were utilized to confirm the results. Finally, our findings were validated based on two independent external validation datasets, GSE17536 and GSE39582. The real-world tissue dataset with corresponding immunohistochemical (IHC) experiments was utilized to confirm our findings. We determined that the majority of PACs were fibroblasts. On top of that, this study identified ADAMDEC1 as a gene that has a significant causal association with overall survival. ADAMDEC1, highly expressed in highly differentiated fibroblasts, was ascertained its high expression was linked with a better prognosis of patients with colon cancer by the related bulk transcriptome analysis. Our dataset presented that higher IHC scores were associated with a better prognosis for colon cancer, further validating our results. This study has identified ADAMDEC1 as a prognostic protective factor for patients with colon cancer, providing clues for clinical trials and drug experimental target research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China.
- Department of Nutrition and Food Hygiene, School of Public Health, Chongqing Medical University, Chongqing, China.
- Research Centre for Environment and Human Health, School of Public Health, Chongqing Medical University, Chongqing, China.
- Nutrition Innovation Platform-Sichuan and Chongqing, School of Public Health, Chongqing Medical University, Chongqing, China.
- Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China. zhongxiaoni@cqmu.edu.cn.
- Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing, 400016, China. kybiao@cqmu.edu.cn.
ORCID-Profile: Biao Xie
Förderung
- National Youth Science Foundation Project
- Science and Technology Research Program of Chongqing Municipal Education Commission
- Chongqing Maternal and Child Disease Prevention and Control and Public Health Research Center Open Project
Zitieren
APA
Zhang, C., Shi, D., Lai, G., Li, K., Zhang, Y., Li, W., Zeng, H., Yan, Q., Zhong, X., & Xie, B. (2025). A transcriptome-wide association study integrating multi-omics bioinformatics and Mendelian randomization reveals the prognostic value of ADAMDEC1 in colon cancer. Archives of Toxicology, 99(2), 645-665. https://doi.org/10.1007/s00204-024-03910-3
Vancouver
Zhang C, Shi D, Lai G, Li K, Zhang Y, Li W, et al. A transcriptome-wide association study integrating multi-omics bioinformatics and Mendelian randomization reveals the prognostic value of ADAMDEC1 in colon cancer. Archives of Toxicology. 2025;99(2):645-665. doi:10.1007/s00204-024-03910-3
BibTeX
@article{Zhang2025,
author = {Zhang, Cong and Shi, Dan and Lai, Guichuan and Li, Kangjie and Zhang, Yuan and Li, Wenlong and Zeng, Haijiao and Yan, Qiaoping and Zhong, Xiaoni and Xie, Biao},
title = {A transcriptome-wide association study integrating multi-omics bioinformatics and Mendelian randomization reveals the prognostic value of ADAMDEC1 in colon cancer},
journal = {Archives of Toxicology},
year = {2025},
volume = {99},
number = {2},
pages = {645--665},
doi = {10.1007/s00204-024-03910-3}
}
EUVIMED